Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3Solid Tumor 2Osteoporosis 1Lymphatic Metastasis 1Lung Neoplasms 1Immunoglobulin Light-chain Amyloidosis 1Endometrial Neoplasms 1Amyloidosis 1

Interventions

Zoledronic Acid 8Vitamin D 6Risedronic Acid 6Calcium 6Letrozole 4Cholecalciferol 4Calcium Carbonate 4Alendronate 3parathyroid hormone-related peptide (1-36) 2bicalutamide 2Resistance Training 2Nutrition Assessment 2Goserelin 2Estradiol 2Denosumab 2Calcium Gluconate 2Aromatase Inhibitors 2Absorptiometry, Photon 2xian ling gu bao 1romosozumab 1X-Rays 1Technetium 1Raloxifene Hydrochloride 1Progesterone 1Parathyroid Hormone-Related Protein 1Parathyroid Hormone 1Lysine Acetyltransferase 5 1Ibandronic Acid 1Hormone Replacement Therapy 1Geritol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Osteoporosis × Technetium × Clear all
NCT02304757 2021-11-17

99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase NA Completed
142 enrolled 7 charts

Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡